When angel investor Esther Dyson was in Russia, training for a private space flight, she was struck by how rigorously we track the health of astronauts. In the earthbound world, of course, it’s only sick among us who accrue detailed medical records.
“I came back, and I thought: Let’s genoytpe all the astronauts,” recalls Dyson, who sits on the board of the Silicon Valley personal genomics company 23andMe. Exploring the genetic makeup of an unusually healthy population seemed like an irresistible research opportunity. Continue Reading →